IDArubicin Hydrochloride Injection USP 5gm/5mL recall: Particulate Matter
IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva Pharmaceuticals, USA, Inc., North…
Why was IDArubicin Hydrochloride Injection USP 5gm/5mL recalled?
Presence of Particulate Matter: Product was found to contain silica and iron oxide
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 31329657B, Exp. Date 08/2023
- Product
- IDArubicin Hydrochloride Injection USP 5gm/5mL (1mg/mL) for intravenous use, 5mL Single Dose Vial, Rx Only, Teva Pharmaceuticals, USA, Inc., North…
- Recalling firm
- Teva Pharmaceuticals USA Inc
- Quantity
- 1565 vials
- Distribution
- Nationwide within the United States
- Recall date
- April 20, 2022
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)